KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $24.2 million.

  • LifeMD's Cash & Current Investments fell 3592.72% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 3592.72%. This contributed to the annual value of $35.0 million for FY2024, which is 420.19% up from last year.
  • Latest data reveals that LifeMD reported Cash & Current Investments of $24.2 million as of Q3 2025, which was down 3592.72% from $36.5 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Cash & Current Investments registered a high of $41.5 million during Q4 2021, and its lowest value of $4.1 million during Q4 2022.
  • Its 5-year average for Cash & Current Investments is $23.4 million, with a median of $24.2 million in 2025.
  • In the last 5 years, LifeMD's Cash & Current Investments surged by 549450.99% in 2021 and then plummeted by 9016.13% in 2022.
  • Quarter analysis of 5 years shows LifeMD's Cash & Current Investments stood at $41.5 million in 2021, then tumbled by 90.16% to $4.1 million in 2022, then surged by 723.08% to $33.6 million in 2023, then increased by 4.2% to $35.0 million in 2024, then tumbled by 31.03% to $24.2 million in 2025.
  • Its Cash & Current Investments stands at $24.2 million for Q3 2025, versus $36.5 million for Q2 2025 and $34.6 million for Q1 2025.